Home » Stocks » TLGT

Teligent, Inc. (TLGT)

Stock Price: $0.600 USD -0.047 (-7.22%)
Updated Jun 15, 2021 4:00 PM EDT - Market closed
Pre-market: $0.610 +0.010 (1.65%) Jun 16, 8:30 AM
Market Cap 57.18M
Revenue (ttm) 49.45M
Net Income (ttm) -93.03M
Shares Out 58.47M
EPS (ttm) -4.31
PE Ratio n/a
Forward PE 6.29
Dividend n/a
Dividend Yield n/a
Trading Day June 15
Last Price $0.600
Previous Close $0.647
Change ($) -0.047
Change (%) -7.22%
Day's Open 0.652
Day's Range 0.590 - 0.655
Day's Volume 3,254,895
52-Week Range 0.455 - 3.120

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Biotech penny stocks are heating up as Covid cases decline; which small-caps are on your watchlist? The post Trading Biotech Penny Stocks?

Other stocks mentioned: JAGX, SEEL
2 weeks ago - PennyStocks

Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare ...

3 weeks ago - Benzinga

BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and p...

3 weeks ago - GlobeNewsWire

BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conferenc...

3 weeks ago - GlobeNewsWire

BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year end...

1 month ago - GlobeNewsWire

BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and a...

2 months ago - GlobeNewsWire

BUENA, N.J., Feb. 23, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Car...

3 months ago - PRNewsWire

BUENA, N.J., Feb. 16, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed ind...

4 months ago - PRNewsWire

BUENA, N.J., Jan. 28, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced a series of strategi...

4 months ago - PRNewsWire

BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from T...

4 months ago - GlobeNewsWire

BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter end...

5 months ago - GlobeNewsWire

Shares of TLGT stock are soaring on Monday ahead of a special shareholder vote to address Teligent's Nasdaq compliance. The post Teligent: 7 Things for Investors to Know About TLGT Stock appeared first ...

6 months ago - InvestorPlace

Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote

6 months ago - GlobeNewsWire

LOS ANGELES--(BUSINESS WIRE)---- $TLGT #TLGT--TLGT LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teligent, Inc.

8 months ago - Business Wire

BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the i...

8 months ago - GlobeNewsWire

Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ...

9 months ago - GlobeNewsWire

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on We...

10 months ago - GlobeNewsWire

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the is...

10 months ago - GlobeNewsWire

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that Joh...

10 months ago - GlobeNewsWire

BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of P...

10 months ago - GlobeNewsWire

BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it receive...

11 months ago - GlobeNewsWire

BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion rate...

1 year ago - GlobeNewsWire

BUENA, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that as of 12:01...

1 year ago - GlobeNewsWire

Teligent's (TLGT) CEO Tim Sawyer on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of Teligent (NASDAQ:TLGT) moved higher by 34% in pre-market trading after the company reported Q1 results.

1 year ago - Benzinga

BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter en...

1 year ago - GlobeNewsWire

Teligent, Inc. (TLGT) CEO Tim Sawyer on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of Teligent (NASDAQ:TLGT) rose 11% in pre-market trading after the company reported Q4 results.

1 year ago - Benzinga

BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter...

1 year ago - GlobeNewsWire

BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition in...

1 year ago - GlobeNewsWire

BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a Comple...

1 year ago - GlobeNewsWire

Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Teligent (TLGT) delivered earnings and revenue surprises of -100.00% and -6.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Teligent: 100% Upside Based On Revised SOTP With Several Near-Term Catalysts

1 year ago - Seeking Alpha

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of $34,40...

1 year ago - GlobeNewsWire

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has filed a prior approval supplement...

1 year ago - GlobeNewsWire

BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abb...

1 year ago - GlobeNewsWire

BUENA, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Teligent Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has retained SVB Leerink as its financ...

1 year ago - GlobeNewsWire

TLGT is a rapidly growing micro-cap specialty generic manufacturer with 200%+ upside potential over the next 12-18 months.

1 year ago - Seeking Alpha

TLGT is a rapidly growing micro-cap specialty generic manufacturer with 200%+ upside potential over the next 12-18 months.

1 year ago - Seeking Alpha

Teligent's (TLGT) CEO Jason Grenfell-Gardner on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Teligent (TLGT) delivered earnings and revenue surprises of 0.00% and 4.36%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Teligent (TLGT) delivered earnings and revenue surprises of -50.00% and -20.95%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About TLGT

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical cust... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1977
CEO
Timothy Sawyer
Employees
146
Stock Exchange
NASDAQ
Ticker Symbol
TLGT
Full Company Profile

Financial Performance

In 2020, Teligent's revenue was $45.31 million, a decrease of -31.24% compared to the previous year's $65.90 million. Losses were -$122.02 million, 385.7% more than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Teligent stock is "Hold" and the 12-month stock price forecast is 1.00.

Price Target
$1.00
Analyst Consensus: Hold